Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.512
Buy
RSI(14)
62.026
Neutral
STOCH(KDJ)(9,3,3)
77.581
Neutral
ATR(14)
1.433
Low Volatility
CCI(14)
76.290
Neutral
Williams %R
22.634
Buy
TRIX(12,20)
0.985
Sell
StochRSI(14)
0.000
Sell
Search
Enovis Corp
ENOVAdd to Watchlist
29.150USD
-0.140-0.48%
Close 07-31 16:00（ET）Quotes delayed by 15 min
1.68BMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey ChartIntraday
1m
30m
1h
D
W
M
D
Today
-0.48%
5 Days
+7.84%
1 Month
+29.56%
6 Months
+31.48%
Year to Date
+9.42%
1 Year
+13.25%
Key Figures
28.790Open
29.310High
770.28KVolume
LossP/E TTM
7.00P/E Dynamic
--Dividend TTM
1.34%Turnover Ratio
29.300Prev. Close
28.216Low
12.32MTurnover
LossP/E Static
1.14P/B
0.00%Div Yield TTM
-26.06%ROA
38.19052wk High
0.79Volume Ratio
-825.49MNet Profit
57.55MShares
-19.9221EPS TTM
1.23Beta
-55.46%ROE
21.00052wk Low
3.73%Amplitude
54.92%Gross Margin
1.68BMarket Cap
3.95Reward/Risk
3.32%Risk Rate
TradingKey Stock Score of Enovis Corp
Currency: USD Updated: 2026-07-31Key Insights
Enovis Corp's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 28 out of 199 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 41.92.In the medium term, the stock price is expected to trend up.Despite a good stock market performance and outperforming fundamentals over the past month, the technicals don't support the current trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Enovis Corp's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Enovis Corp Highlights
StrengthsRisks
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 31.68% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 2.25B.
Overvalued
The company’s latest PE is -1.46, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 68.97M shares, decreasing 8.93% quarter-over-quarter.
Held by Mason Hawkins
Star Investor Mason Hawkins holds 43.70K shares of this stock.
Analyst Rating
Based on
13
analysts
Buy
Current Rating
41.917
Target Price
+43.80%
Upside Space
Enovis Corp News
More news coming soon, stay tuned...
Earnings Forecast
Analyst Rating
Based on
13
analysts
Buy
Current Rating
41.917
Target Price
+43.80%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
109
Total
7
Median
9
Average
Company name
Ratings
Analysts
Enovis Corp
ENOV
13
Medtronic PLC
MDT
34
Stryker Corp
SYK
32
Dexcom Inc
DXCM
32
Zimmer Biomet Holdings Inc
ZBH
31
Abbott Laboratories
ABT
29
1
2
3
...
22
Indicators
Moving Average
Indicators
Value
Direction
MA5
29.296
Sell
MA10
28.006
Buy
MA20
26.885
Buy
MA50
24.192
Buy
MA100
24.081
Buy
MA200
25.490
Buy
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Enovis Corp Info
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).
Ticker SymbolENOV
CompanyEnovis Corp
CEOMcdonald (Damien)
Websitehttps://www.enovis.com/
Shareholders
Related Instruments
-1.72%
-0.43%
+0.12%
-0.59%
-0.74%
-6.42%
+0.10%
-0.36%
+1.75%
-0.14%
-2.99%
+1.58%
-0.29%
+0.41%
-1.02%
+0.13%
+0.05%
-0.80%
-0.24%
-0.70%Popular Instruments
52737.200
+359.200 (+0.69%)
28498.100
+337.200 (+1.20%)
7528.900
+53.800 (+0.72%)
14606.000
-143.000 (-0.97%)
62953.000
+101.000 (+0.16%)
6394.200
+28.800 (+0.45%)
79.412
-6.522 (-7.59%)
308.910
-24.520 (-7.35%)
200.750
+5.710 (+2.93%)
4048.370
+6.940 (+0.17%)
FAQs
What is the current price of Enovis Corp (ENOV)?
The current price of Enovis Corp (ENOV) is 29.15.
What is the symbol of Enovis Corp?
The ticker symbol of Enovis Corp is ENOV.
What is the 52-week high of Enovis Corp?
The 52-week high of Enovis Corp is 38.19.
What is the 52-week low of Enovis Corp?
The 52-week low of Enovis Corp is 21.00.
What is the market capitalization of Enovis Corp?
The market capitalization of Enovis Corp is 1.68B.
Is Enovis Corp (ENOV) currently rated as Buy, Hold, or Sell?
According to analysts, Enovis Corp (ENOV) has an overall rating of Buy, with a price target of 41.92.
What is the Earnings Per Share (EPS TTM) of Enovis Corp (ENOV)?
The Earnings Per Share (EPS TTM) of Enovis Corp (ENOV) is -20.75.